Vistagen Therapeutics, Inc. (VTGN) Form 8-K — Jun 17, 2026
Two directors of Vistagen Therapeutics, Inc. have notified the company that they will not stand for re-election at the 2026 Annual Meeting of Stockholders. Ms. Margaret FitzPatrick and Dr.
Price after filing
1 day: 0.0%7 days: -3.7%30 days: -65.2%
Close on the filing date to close N calendar days later (from $0.69). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.